9, rue d'Enghien
Paris 75010
France
33 1 48 24 03 45
https://www.maunakeatech.com
Settore/i:
Settore:
Impiegati a tempo pieno: 67
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Alexandre Loiseau Ph.D. | Co-Founder, CEO & Chairman | 172,64k | N/D | N/D |
Mr. Come de La Tour du Pin | Chief Financial Officer | N/D | N/D | N/D |
Ms. Nathalie Lecoq | Chief Operating Officer | N/D | N/D | N/D |
Mr. Frederic Banegas Ph.D. | Chief Technology Officer | N/D | N/D | N/D |
Mr. François Lacombe Ph.D. | Chief Scientific Officer | N/D | N/D | N/D |
Mr. Daryl Donatelli | Vice President of Global Marketing & U.S. Sales | N/D | N/D | N/D |
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company offers range of medical devices, which includes gastroenterology, pulmonology, urology, and drug development. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
L'ISS Governance QualityScore di Mauna Kea Technologies SA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.